Caspase-8, c-FLIP, and caspase-9 in c-Myc-induced apoptosis of fibroblasts

Experimental Cell Research

Volumn 317, Issue 18, 2011, Pages 2602-2615

  Järvinen, Kristiina ^a   Hotti, Anneli ^a   Santos, Leticia ^a   Nummela, Pirjo ^a   Hölttä, Erkki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Apoptosis; C Myc; Caspases; Fas ligand; FLIP; TNF

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 9; FAS ANTIGEN; FAS LIGAND; FLICE INHIBITORY PROTEIN; MYC PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

RATTUS;

EID: 80053572042     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.08.014     Document Type: Article

References (85)

1. Zeller K.I., Zhao X., Lee C.W., Chiu K.P., Yao F., Yustein J.T., Ooi H.S., Orlov Y.L., Shahab A., Yong H.C., Fu Y., Weng Z., Kuznetsov V.A., Sung W.K., Ruan Y., Dang C.V., Wei C.L. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17834-17839.
2. Nilsson J.A., Cleveland J.L. Myc pathways provoking cell suicide and cancer. Oncogene 2003, 22:9007-9021.
3. Meyer N., Kim S.S., Penn L.Z. The oscar-worthy role of Myc in apoptosis. Semin. Cancer Biol. 2006, 16:275-287.
4. Hoffman B., Liebermann D.A. Apoptotic signaling by c-MYC. Oncogene 2008, 27:6462-6472.
5. Larsson L.G., Henriksson M.A. The yin and yang functions of the Myc oncoprotein in cancer development and as targets for therapy. Exp. Cell Res. 2010, 316:1429-1437.
6. Hueber A.O., Zornig M., Lyon D., Suda T., Nagata S., Evan G.I. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 1997, 278:1305-1309.
7. Kagaya S., Kitanaka C., Noguchi K., Mochizuki T., Sugiyama A., Asai A., Yasuhara N., Eguchi Y., Tsujimoto Y., Kuchino Y. A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis. Mol. Cell. Biol. 1997, 17:6736-6745.
8. Kangas A., Nicholson D.W., Holtta E. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis. Oncogene 1998, 16:387-398.
9. Juin P., Hueber A.O., Littlewood T., Evan G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 1999, 13:1367-1381.
10. Soengas M.S., Alarcon R.M., Yoshida H., Giaccia A.J., Hakem R., Mak T.W., Lowe S.W. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 1999, 284:156-159.
11. Hotti A., Jarvinen K., Siivola P., Holtta E. Caspases and mitochondria in c-myc-induced apoptosis: identification of ATM as a new target of caspases. Oncogene 2000, 19:2354-2362.
12. Elliott K., Ge K., Du W., Prendergast G.C. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program. Oncogene 2000, 19:4669-4684.
13. Nieminen A.I., Partanen J.I., Klefstrom J. c-Myc blazing a trail of death: coupling of the mitochondrial and death receptor apoptosis pathways by c-myc. Cell Cycle 2007, 6:2464-2472.
14. Hengartner M.O. The biochemistry of apoptosis. Nature 2000, 407:770-776.
15. Boatright K.M., Salvesen G.S. Mechanisms of caspase activation. Curr. Opin. Cell Biol. 2003, 15:725-731.
16. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
17. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 1999, 17:331-367.
18. Peter M.E., Krammer P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003, 10:26-35.
19. Micheau O., Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003, 114:181-190.
20. Chang D.W., Xing Z., Capacio V.L., Peter M.E., Yang X. Interdimer processing mechanism of procaspase-8 activation. EMBO J. 2003, 22:4132-4142.
21. Lamkanfi M., Declercq W., Kalai M., Saelens X., Vandenabeele P. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ. 2002, 9:358-361.
22. Reed J.C., Doctor K., Rojas A., Zapata J.M., Stehlik C., Fiorentino L., Damiano J., Roth W., Matsuzawa S., Newman R., Takayama S., Marusawa H., Xu F., Salvesen G., Godzik A. RIKEN GER Group, GSL Members, Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res. 2003, 13:1376-1388.
23. Janicke R.U., Sohn D., Totzke G., Schulze-Osthoff K. Caspase-10 in mouse or not?. Science 2006, 312:1874.
24. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L.E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195.
25. Shirley, S., Micheau, O. Targeting c-FLIP in cancer, Cancer Lett. (in press), doi:. doi:10.1016/j.canlet.2010.10.009.
26. Hu S., Vincenz C., Ni J., Gentz R., Dixit V.M. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. J. Biol. Chem. 1997, 272:17255-17257.
27. Shu H.B., Halpin D.R., Goeddel D.V. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 1997, 6:751-763.
28. Golks A., Brenner D., Fritsch C., Krammer P.H., Lavrik I.N. c-FLIPR, a new regulator of death receptor-induced apoptosis. J. Biol. Chem. 2005, 280:14507-14513.
29. Yu J.W., Shi Y. FLIP and the death effector domain family. Oncogene 2008, 27:6216-6227.
30. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 2001, 15:2922-2933.
31. Cain K., Bratton S.B., Langlais C., Walker G., Brown D.G., Sun X.M., Cohen G.M. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J. Biol. Chem. 2000, 275:6067-6070.
32. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
33. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Alnemri E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1998, 1:949-957.
34. Rodriguez J., Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Genes Dev. 1999, 13:3179-3184.
35. Riedl S.J., Salvesen G.S. The apoptosome: signalling platform of cell death. Nat. Rev. Mol. Cell Biol. 2007, 8:405-413.
36. Bao Q., Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 2007, 14:56-65.
37. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 1995, 23:1686-1690.
38. Nastiuk K.L., Yoo K., Lo K., Su K., Yeung P., Kutaka J., Danielpour D., Krolewski J.J. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells. Mol. Cancer Res. 2008, 6:231-242.
39. Holtta E., Sistonen L., Alitalo K. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J. Biol. Chem. 1988, 263:4500-4507.
40. Moubarak R.S., Sole C., Pascual M., Gutierrez H., Llovera M., Perez-Garcia M.J., Gozzelino R., Segura M.F., Iglesias-Guimarais V., Reix S., Soler R.M., Davies A.M., Soriano E., Yuste V.J., Comella J.X. The death receptor antagonist FLIP-L interacts with Trk and is necessary for neurite outgrowth induced by neurotrophins. J. Neurosci. 2010, 30:6094-6105.
41. Yang W., Shen J., Wu M., Arsura M., FitzGerald M., Suldan Z., Kim D.W., Hofmann C.S., Pianetti S., Romieu-Mourez R., Freedman L.P., Sonenshein G.E. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 2001, 20:1688-1702.
42. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Litwack G., Alnemri E.S. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14486-14491.
43. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Green D.R., Martin S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 1999, 144:281-292.
44. Scaffidi C., Medema J.P., Krammer P.H., Peter M.E. FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. Biol. Chem. 1997, 272:26953-26958.
45. Yoo K.S., Nastiuk K.L., Krolewski J.J. Transforming growth factor beta1 induces apoptosis by suppressing FLICE-like inhibitory protein in DU145 prostate epithelial cells. Int. J. Cancer 2009, 124:834-842.
46. Luo X., Budihardjo I., Zou H., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490.
47. Iaccarino I., Hancock D., Evan G., Downward J. c-Myc induces cytochrome c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner. Cell Death Differ. 2003, 10:599-608.
48. Sarig R., Zaltsman Y., Marcellus R.C., Flavell R., Mak T.W., Gross A. BID-D59A is a potent inducer of apoptosis in primary embryonic fibroblasts. J. Biol. Chem. 2003, 278:10707-10715.
49. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997, 90:405-413.
50. Bratton S.B., Walker G., Roberts D.L., Cain K., Cohen G.M. Caspase-3 cleaves Apaf-1 into an approximately 30kDa fragment that associates with an inappropriately oligomerized and biologically inactive approximately 1.4 MDa apoptosome complex. Cell Death Differ. 2001, 8:425-433.
51. Lauber K., Appel H.A., Schlosser S.F., Gregor M., Schulze-Osthoff K., Wesselborg S. The adapter protein apoptotic protease-activating factor-1 (Apaf-1) is proteolytically processed during apoptosis. J. Biol. Chem. 2001, 276:29772-29781.
52. Fujita E., Egashira J., Urase K., Kuida K., Momoi T. Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ. 2001, 8:335-344.
53. Cowling V., Downward J. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ. 2002, 9:1046-1056.
54. Sohn D., Schulze-Osthoff K., Janicke R.U. Caspase-8 can be activated by interchain proteolysis without receptor-triggered dimerization during drug-induced apoptosis. J. Biol. Chem. 2005, 280:5267-5273.
55. Wajant H., Johannes F.J., Haas E., Siemienski K., Schwenzer R., Schubert G., Weiss T., Grell M., Scheurich P. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr. Biol. 1998, 8:113-116.
56. Hueber A.O., Bosser S., Zornig M. Transgenic overexpression of a dominant negative mutant of FADD that, although counterselected during tumor progression, cooperates in L-myc-induced tumorigenesis. Int. J. Cancer 2004, 112:536-540.
57. Wang Y., Engels I.H., Knee D.A., Nasoff M., Deveraux Q.L., Quon K.C. Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell 2004, 5:501-512.
58. Ahn J.H., Park S.M., Cho H.S., Lee M.S., Yoon J.B., Vilcek J., Lee T.H. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J. Biol. Chem. 2001, 276:47100-47106.
59. Kataoka T., Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol. Cell. Biol. 2004, 24:2627-2636.
60. Golks A., Brenner D., Krammer P.H., Lavrik I.N. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation. J. Exp. Med. 2006, 203:1295-1305.
61. McStay G.P., Salvesen G.S., Green D.R. Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ. 2008, 15:322-331.
62. Pop C., Salvesen G.S. Human caspases: activation, specificity, and regulation. J. Biol. Chem. 2009, 284:21777-21781.
63. Scott C.L., Schuler M., Marsden V.S., Egle A., Pellegrini M., Nesic D., Gerondakis S., Nutt S.L., Green D.R., Strasser A. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation. J. Cell Biol. 2004, 164:89-96.
64. Hasenjager A., Gillissen B., Muller A., Normand G., Hemmati P.G., Schuler M., Dorken B., Daniel P.T. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells. Oncogene 2004, 23:4523-4535.
65. Egle A., Harris A.W., Bouillet P., Cory S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6164-6169.
66. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 1998, 17:1675-1687.
67. Engels I.H., Stepczynska A., Stroh C., Lauber K., Berg C., Schwenzer R., Wajant H., Janicke R.U., Porter A.G., Belka C., Gregor M., Schulze-Osthoff K., Wesselborg S. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 2000, 19:4563-4573.
68. von Haefen C., Wieder T., Essmann F., Schulze-Osthoff K., Dorken B., Daniel P.T. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. Oncogene 2003, 22:2236-2247.
69. Inoue S., Browne G., Melino G., Cohen G.M. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ. 2009, 16:1053-1061.
70. Kasibhatla S., Beere H.M., Brunner T., Echeverri F., Green D.R. A "non-canonical" DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc. Curr. Biol. 2000, 10:1205-1208.
71. Yeh W.C., Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A., Ng M., Wakeham A., Khoo W., Mitchell K., El-Deiry W.S., Lowe S.W., Goeddel D.V., Mak T.W. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 1998, 279:1954-1958.
72. Cameron E.R., Morton J., Johnston C.J., Irvine J., Bell M., Onions D.E., Neil J.C., Campbell M., Blyth K. Fas-independent apoptosis in T-cell tumours induced by the CD2-myc transgene. Cell Death Differ. 2000, 7:80-88.
73. Ricci M.S., Jin Z., Dews M., Yu D., Thomas-Tikhonenko A., Dicker D.T., El-Deiry W.S. Direct repression of FLIP expression by c-myc is a major determinant of TRAIL sensitivity. Mol. Cell. Biol. 2004, 24:8541-8555.
74. Chandramohan V., Mineva N.D., Burke B., Jeay S., Wu M., Shen J., Yang W., Hann S.R., Sonenshein G.E. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor. J. Cell. Biochem. 2008, 104:2091-2106.
75. Patel J.H., McMahon S.B. Targeting of Miz-1 is essential for Myc-mediated apoptosis. J. Biol. Chem. 2006, 281:3283-3289.
76. Krueger A., Schmitz I., Baumann S., Krammer P.H., Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 2001, 276:20633-20640.
77. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., Peter M.E., Yang X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002, 21:3704-3714.
78. Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W., Briand C., Grutter M.G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 2002, 277:45162-45171.
79. Zhang X., Jin T.G., Yang H., DeWolf W.C., Khosravi-Far R., Olumi A.F. Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer. Cancer Res. 2004, 64:7086-7091.
80. Sharp D.A., Lawrence D.A., Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J. Biol. Chem. 2005, 280:19401-19409.
81. Wilson T.R., McLaughlin K.M., McEwan M., Sakai H., Rogers K.M., Redmond K.M., Johnston P.G., Longley D.B. c-FLIP: a key regulator of colorectal cancer cell death. Cancer Res. 2007, 67:5754-5762.
82. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A., Mirtsos C., Suzuki N., Bonnard M., Goeddel D.V., Mak T.W. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000, 12:633-642.
83. Jin T.G., Kurakin A., Benhaga N., Abe K., Mohseni M., Sandra F., Song K., Kay B.K., Khosravi-Far R. Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5. J. Biol. Chem. 2004, 279:55594-55601.
84. Fernandez P.C., Frank S.R., Wang L., Schroeder M., Liu S., Greene J., Cocito A., Amati B. Genomic targets of the human c-Myc protein. Genes Dev. 2003, 17:1115-1129.
85. Mashima T., Naito M., Noguchi K., Miller D.K., Nicholson D.W., Tsuruo T. Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 1997, 14:1007-1012.